Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide

Abstract Hydroxycarbamide (HC) is used as a cytoreductive treatment in myeloproliferative neoplasms (MPN). Observational studies have raised the possibility that HC contributes to the development of secondary malignancies, including skin tumours in MPN patients. In this retrospective observational s...

Description complète

Détails bibliographiques

Auteurs principaux:	Abhinav Mathur, Joakim Edman, Livia Liang, Neil W. Scott, Henry G. Watson
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2022-11-01
Collection:	eJHaem
Sujets:	essential thrombocythaemia hydroxycarbamide melanoma myeloproliferative neoplasm non‐melanoma skin cancer polycythaemia vera
Accès en ligne:	https://doi.org/10.1002/jha2.551
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!